Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GLK-302 by Glaukos for Presbyopia: Likelihood of Approval
GLK-302 is under clinical development by Glaukos and currently in Phase II for Presbyopia. According to GlobalData, Phase II drugs...